A new erection-enhancing condom, informally dubbed “the Viagra condom,” is awaiting regulatory approval in Europe and could appear on the shelves of European pharmacies and supermarkets by the end of the year, The Wall Street Journal reports. The product is licensed to SSL International, the owner of Durex, the world’s top-selling condom brand. The new condom uses a gel that contains an agent designed to boost blood flow without degrading latex. The new condom specifically targets men who have difficulty maintaining an erection while wearing a condom.

To read the Journal article, click here.